The SOPHiA DDMTM Platform: Deep dive on how we support solid tumor detection
SOPHiA GENETICS - 2021 CGC Virtual Annual Meeting.
The Cancer Genomics Consortium (CGC - https://cancergenomics.org/) represents a dedicated group of clinical cytogeneticists, molecular geneticists, and molecular pathologists, who are interested in education and promoting best practices in clinical cancer genomics. Our vision is for all cancer patients to be accurately diagnosed for their underlying genomic alterations to help them receive the most appropriate therapy. CGC aims to be the authoritative organization for guidance on the best practice of clinical cancer genomic testing. Please visit https://www.cancergenomics.org/become_a_member.php to become a member and gain full access to our complete library of presentations.
Видео The SOPHiA DDMTM Platform: Deep dive on how we support solid tumor detection канала Cancer Genomics Consortium
The Cancer Genomics Consortium (CGC - https://cancergenomics.org/) represents a dedicated group of clinical cytogeneticists, molecular geneticists, and molecular pathologists, who are interested in education and promoting best practices in clinical cancer genomics. Our vision is for all cancer patients to be accurately diagnosed for their underlying genomic alterations to help them receive the most appropriate therapy. CGC aims to be the authoritative organization for guidance on the best practice of clinical cancer genomic testing. Please visit https://www.cancergenomics.org/become_a_member.php to become a member and gain full access to our complete library of presentations.
Видео The SOPHiA DDMTM Platform: Deep dive on how we support solid tumor detection канала Cancer Genomics Consortium
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
CGC Webinar Series: Recommendations for Interpretation of Low Penetrance Variants & Risk Alleles
A Resource for our Clinical Genomics Community: the Compendium of Cancer Genome Aberrations (CCGA)
Invitation to Submit Abstract for CGC 2023 Annual Meeting
Biomarker Discovery through Tumor Profiling
The many genomic roads to acute lymphoblastic leukemia
Characterization of atypical iAMP21 observed in B-Lymphoblastic Leukemia (B-ALL)
Microsatellite Instability Detection with Anchored Multiplex PCR
Ultra Deep Sequencing of Classical Hodgkin Lymphoma cHL Reveals Novel Somatic Mutations and Exemp
Ushering in a New Era for Cytogenomics Based on Optical Genome Mapping
Don’t Simply Automate your FISH and Karyotyping Slide Dropping Workflow
Invited Speaker Presentation-TP53 alterations in myelodysplastic neoplasms & acute myeloid leukemia
CGC 2023 Keynote Presentation - Heterogeneity of breast cancer genomes
Reveal New Insights with the Advanced Sensitivity of Duplex Sequencing
Who’s Driving Treatment? Two Co-Occurring Driver Mutations in Primary Lung Adenocarcinoma
Deconvoluting the heterogeneous signatures of B-cell acute lymphoblastic leukemia
CGC 2022 Invited Presentation - Genetic Ancestry, Somatic Alteration and Outcome
CGC Program Updates
Beyond CNVs: Leveraging SNP Arrays in Cancer
High Resolution Target Capture DNA Analysis for Suspect Clonal Hematopoiesis
CGC 2023 Keynote Presentation - CAR-T Therapies for T cell Malignancies
The Spectrum of NTRK Fusion Associated Pediatric Tumors